H. Bobby Gaspar

9.3k total citations
65 papers, 3.3k citations indexed

About

H. Bobby Gaspar is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, H. Bobby Gaspar has authored 65 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 29 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in H. Bobby Gaspar's work include Virus-based gene therapy research (36 papers), RNA Interference and Gene Delivery (23 papers) and CAR-T cell therapy research (20 papers). H. Bobby Gaspar is often cited by papers focused on Virus-based gene therapy research (36 papers), RNA Interference and Gene Delivery (23 papers) and CAR-T cell therapy research (20 papers). H. Bobby Gaspar collaborates with scholars based in United Kingdom, Germany and United States. H. Bobby Gaspar's co-authors include Adrian J. Thrasher, Kimberly Gilmour, Paul Veys, Christine Kinnon, Persis Amrolia, Joanna Sinclair, E. Graham Davies, Waseem Qasim, Steven J. Howe and Kathryn L. Parsley and has published in prestigious journals such as The Lancet, Nature Communications and Blood.

In The Last Decade

H. Bobby Gaspar

64 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Bobby Gaspar United Kingdom 32 1.7k 1.4k 1.1k 967 783 65 3.3k
Salima Hacein‐Bey‐Abina France 31 2.1k 1.2× 2.1k 1.5× 1.1k 0.9× 1.1k 1.1× 534 0.7× 84 3.7k
Paolo Servida Italy 12 1.8k 1.0× 1.5k 1.0× 696 0.6× 1.3k 1.4× 512 0.7× 17 2.9k
Isabelle André‐Schmutz France 27 907 0.5× 1.1k 0.8× 1.5k 1.3× 481 0.5× 512 0.7× 78 3.0k
Françoise Selz France 20 1.5k 0.9× 1.7k 1.2× 1.4k 1.3× 743 0.8× 229 0.3× 32 3.5k
Brigitte Sénéchal United States 18 631 0.4× 813 0.6× 1.6k 1.4× 2.3k 2.4× 307 0.4× 43 4.0k
Christophe Hue France 16 1.5k 0.9× 1.7k 1.2× 714 0.6× 648 0.7× 298 0.4× 23 2.7k
Johanne Kaplan United States 28 933 0.5× 1.4k 1.0× 1.1k 1.0× 670 0.7× 131 0.2× 75 3.0k
Siobhan O. Burns United Kingdom 27 867 0.5× 788 0.6× 1.5k 1.4× 344 0.4× 292 0.4× 87 3.2k
Joeri L. Aerts Belgium 30 430 0.2× 1.3k 1.0× 1.2k 1.1× 827 0.9× 915 1.2× 69 3.4k
Shoshana Morecki Israel 24 955 0.6× 909 0.6× 1.0k 0.9× 774 0.8× 777 1.0× 72 2.4k

Countries citing papers authored by H. Bobby Gaspar

Since Specialization
Citations

This map shows the geographic impact of H. Bobby Gaspar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Bobby Gaspar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Bobby Gaspar more than expected).

Fields of papers citing papers by H. Bobby Gaspar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Bobby Gaspar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Bobby Gaspar. The network helps show where H. Bobby Gaspar may publish in the future.

Co-authorship network of co-authors of H. Bobby Gaspar

This figure shows the co-authorship network connecting the top 25 collaborators of H. Bobby Gaspar. A scholar is included among the top collaborators of H. Bobby Gaspar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Bobby Gaspar. H. Bobby Gaspar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaspar, H. Bobby, et al.. (2022). Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier. Molecular Therapy. 31(3). 657–675. 11 indexed citations
2.
Roppelt, Anna, et al.. (2022). Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency. Journal of Clinical Immunology. 43(2). 440–451. 8 indexed citations
3.
Vetharoy, Winston, Uimook Choi, Christine Rivat, et al.. (2021). Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47 phox -Deficient Chronic Granulomatous Disease. Human Gene Therapy. 32(17-18). 949–958. 4 indexed citations
4.
Kreins, Alexandra Y., Kanchan Rao, Paul Veys, et al.. (2021). Long-Term Immune Recovery After Hematopoietic Stem Cell Transplantation for ADA Deficiency: a Single-Center Experience. Journal of Clinical Immunology. 42(1). 94–107. 8 indexed citations
5.
Izotova, Natalia, Christine Rivat, Cristina Baricordi, et al.. (2021). Long-term lymphoid progenitors independently sustain naïve T and NK cell production in humans. Nature Communications. 12(1). 1622–1622. 4 indexed citations
6.
Ghosh, Sujal & H. Bobby Gaspar. (2017). Gene Therapy Approaches to Immunodeficiency. Hematology/Oncology Clinics of North America. 31(5). 823–834. 6 indexed citations
7.
Slatter, Mary, Kanchan Rao, Intan Juliana Abd Hamid, et al.. (2017). Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience. Biology of Blood and Marrow Transplantation. 24(3). 529–536. 60 indexed citations
8.
Gaspar, H. Bobby, et al.. (2016). Adenosine Deaminase Deficiency – More Than Just an Immunodeficiency. Frontiers in Immunology. 7. 314–314. 86 indexed citations
9.
Worth, Austen, Rosie Hague, Nuria Martinez-Alier, et al.. (2015). Adenosine Deaminase Deficient Severe Combined Immunodeficiency Presenting as Atypical Haemolytic Uraemic Syndrome. Journal of Clinical Immunology. 35(4). 366–372. 10 indexed citations
10.
Carmo, Marlene, Kimberly Risma, Paritha Arumugam, et al.. (2014). Perforin Gene Transfer Into Hematopoietic Stem Cells Improves Immune Dysregulation in Murine Models of Perforin Deficiency. Molecular Therapy. 23(4). 737–745. 37 indexed citations
11.
Buckland, Karen & H. Bobby Gaspar. (2014). Gene and cell therapy for children — New medicines, new challenges?. Advanced Drug Delivery Reviews. 73. 162–169. 32 indexed citations
12.
Butler, Stephen, et al.. (2011). Social outcome in children treated by haematopoietic cell transplant for congenital immunodeficiency. Bone Marrow Transplantation. 46(10). 1314–1320. 9 indexed citations
13.
Grigoriadou, Sofia, et al.. (2011). Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clinical & Experimental Immunology. 163(3). 271–283. 112 indexed citations
14.
15.
Gaspar, H. Bobby & Adrian J. Thrasher. (2005). Gene therapy for severe combined immunodeficiencies. Expert Opinion on Biological Therapy. 5(9). 1175–1182. 32 indexed citations
16.
Kampmann, Beate, David Cubitt, Tony Walls, et al.. (2005). Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. British Journal of Haematology. 130(4). 595–603. 107 indexed citations
17.
Plunkett, Fiona J., Ornella Franzese, Jean M. Fletcher, et al.. (2005). The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mechanisms of Ageing and Development. 126(8). 855–865. 62 indexed citations
18.
Qasim, Waseem, H. Bobby Gaspar, & Adrian J. Thrasher. (2005). T Cell Suicide Gene Therapy to Aid Haematopoietic Stem Cell Transplantation. Current Gene Therapy. 5(1). 121–132. 4 indexed citations
19.
Qasim, Waseem, H. Bobby Gaspar, & Adrian J. Thrasher. (2004). Gene therapy for severe combined immune deficiency. Expert Reviews in Molecular Medicine. 6(4). 1–15. 50 indexed citations
20.
Qasim, Waseem, et al.. (2003). The impact of retroviral suicide gene transduction procedures on T cells. British Journal of Haematology. 123(4). 712–719. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salima Hacein‐Bey‐Abina Breakdown of academic impact, for papers by Paolo Servida Breakdown of academic impact, for papers by Isabelle André‐Schmutz Breakdown of academic impact, for papers by Françoise Selz Breakdown of academic impact, for papers by Brigitte Sénéchal Breakdown of academic impact, for papers by Christophe Hue Breakdown of academic impact, for papers by Johanne Kaplan Breakdown of academic impact, for papers by Siobhan O. Burns Breakdown of academic impact, for papers by Joeri L. Aerts Breakdown of academic impact, for papers by Shoshana Morecki
Rankless by CCL
2026